Clinical study on topical use of granulocyte-macrophage colony-stimulating factor combined with oral administration of linezolid in treatment of residual wounds of severe burn injury with methicillin resistant Staphylococcus aureus infection

doi:10.3969/j.issn.1672-8521.2015.03.008

Home>Articles>Clinical study on topical use of granulocyte-macrophage colony-stimulating factor combined with oral administration of linezolid in treatment of residual wounds of severe burn injury with methicillin resistant Staphylococcus aureus infection

DOI: 10.3969/j.issn.1672-8521.2015.03.008

Clinical study on topical use of granulocyte-macrophage colony-stimulating factor combined with oral administration of linezolid in treatment of residual wounds of severe burn injury with methicillin resistant Staphylococcus aureus infection

Keywords：Recombinant human granulocyte-macrophage colony-stimulating factorLinezolidResidual wound

Publication Date：2015-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 162-164,封2 )

Infection Inflammation Repair

ISTIC

ISSN：1672-8521

Year, Vol.(Issue)：2015,16(3)